Published in Neurology on October 01, 1992
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Paraneoplastic syndromes of the CNS. Lancet Neurol (2008) 4.62
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A (1996) 2.52
Antibodies and neuronal autoimmune disorders of the CNS. J Neurol (2009) 2.40
Paraneoplastic neurological syndromes. Orphanet J Rare Dis (2007) 2.32
Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (1996) 1.89
Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry (1999) 1.77
Congenital motor nystagmus linked to Xq26-q27. Am J Hum Genet (1999) 1.45
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39
The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev (1999) 1.32
Paraneoplastic neurologic syndrome: A practical approach. Ann Indian Acad Neurol (2012) 1.23
An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol (2006) 1.21
Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol (2010) 1.14
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry (2004) 1.11
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. Clin Exp Immunol (2006) 0.98
'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation (2015) 0.98
Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation (2009) 0.97
Paraneoplastic and other autoimmune disorders of the central nervous system. Neurohospitalist (2013) 0.97
Clinical insights into paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry (2006) 0.97
Paraneoplastic cerebellar degeneration associated with ovarian cancer. Oncol Lett (2012) 0.96
A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A (2007) 0.96
'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII. J Neuroinflammation (2015) 0.94
The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One (2010) 0.94
A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J Neuroinflammation (2010) 0.94
Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. J Neuroinflammation (2014) 0.92
The Diagnosis and Treatment of Autoimmune Encephalitis. J Clin Neurol (2016) 0.92
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation (2013) 0.92
Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung. Case Rep Neurol Med (2013) 0.91
Update on neurological paraneoplastic syndromes. Curr Opin Oncol (2015) 0.90
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias. Cerebellum (2016) 0.88
Paraneoplastic disorders. Continuum (Minneap Minn) (2015) 0.86
Autoimmune epilepsies. Neurotherapeutics (2014) 0.86
Paraneoplastic neurological syndromes associated with ovarian tumors. J Cancer Res Clin Oncol (2014) 0.84
Paraneoplastic optic neuropathy associated with cerebellar choroid meningioma. Eye (Lond) (2013) 0.83
Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy. BMC Psychiatry (2015) 0.81
Paraneoplastic disorders of eye movements. Ann N Y Acad Sci (2011) 0.80
Need for a paradigm shift in therapeutic approaches to CNS injury. Expert Rev Neurother (2012) 0.80
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration. J Neurol (2005) 0.79
Breast cancer revealed by a paraneoplastic cerebellar syndrome: about one case and literature review. Pan Afr Med J (2015) 0.79
Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells. Acta Neuropathol (1993) 0.79
Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration. J Neurol (2007) 0.78
Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies. J Neurol (2007) 0.78
Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary. BMJ Case Rep (2014) 0.78
Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol (2016) 0.78
Neuroimaging in dementia. Semin Neurol (2008) 0.78
Update on paraneoplastic neurologic disorders. Oncologist (2010) 0.77
Cell-mediated immune responses in paraneoplastic neurological syndromes. Clin Dev Immunol (2013) 0.76
Autoimmune channelopathies of the nervous system. Curr Neuropharmacol (2011) 0.76
Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol (2009) 0.76
Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-yo antibody mediated paraneoplastic cerebellar degeneration. Ann Indian Acad Neurol (2014) 0.76
Paraneoplastic Diseases of the Nervous System. Curr Treat Options Neurol (1999) 0.76
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration. Neuro Oncol (2012) 0.76
Clinical utility gene card for: 16p12.2 microdeletion. Eur J Hum Genet (2016) 0.75
What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review. BMC Psychiatry (2017) 0.75
The role of breast MRI in the investigation of anti-Yo positive paraneoplastic cerebellar degeneration. BMJ Case Rep (2012) 0.75
Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review. Ann Clin Transl Neurol (2016) 0.75
Potential Autoepitope within the Extracellular Region of Contactin-Associated Protein-like 2 in Mice. Br J Med Med Res (2014) 0.75
Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject. Surg Case Rep (2015) 0.75
Paraneoplastic encephalo-myelo-ganglionitis: cellular binding sites of the antineuronal antibody. Acta Neuropathol (1994) 0.75
Spinal anaesthesia for a caesarean section in a patient with paraneoplastic cerebellar ataxia. Indian J Anaesth (2017) 0.75
Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration. Cell Death Dis (2016) 0.75
Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report. Pan Afr Med J (2014) 0.75
Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries. Childs Nerv Syst (2015) 0.75
Pathological findings of anti-Yo cerebellar degeneration with Holmes tremor. J Neurol Neurosurg Psychiatry (2014) 0.75
A rare case of breast carcinoma presenting with paraneoplastic cerebellar degeneration. J Surg Case Rep (2010) 0.75
Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer. BMC Clin Pathol (2014) 0.75
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. J Neurol (2010) 0.75
Magnetic Oculomotor Prosthetics for Acquired Nystagmus. Ophthalmology (2017) 0.75
Anti-Yo positive dorsal root ganglionopathy. J Neurol (2010) 0.75
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95
Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98
Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 3.58
HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell (1991) 3.33
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
Distribution of brain metastases. Arch Neurol (1988) 3.11
Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81
Radiation-induced dementia in patients cured of brain metastases. Neurology (1989) 2.59
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58
Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev (1998) 2.55
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol (2001) 2.15
Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology (1979) 2.13
Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol (1991) 2.08
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05
Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97
Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer (1990) 1.97
Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med (1967) 1.93
Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: report of 4 cases. Am J Surg Pathol (1999) 1.85
Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82
MRI changes in intracranial hypotension. Neurology (1993) 1.80
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70
Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol (1998) 1.70
Radiation therapy for brain metastases. Ann Neurol (1980) 1.68
Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol (1980) 1.68
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66
Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol (1968) 1.66
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology (1990) 1.65
Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol (1988) 1.63
Metastasis to the base of the skull: clinical findings in 43 patients. Neurology (1981) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol (1977) 1.58
Steroid myopathy in cancer patients. Neurology (1997) 1.57
Ataxia in epidural spinal cord compression. Neurology (1992) 1.55
Neurologic complications of carcinoid. Neurology (1986) 1.54
Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion. Acta Neuropathol (1988) 1.52
Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol (2001) 1.47
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46
Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol (1979) 1.42
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol (1995) 1.37
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Swallow syncope. Report of a case and review of the literature. Neurology (1972) 1.35
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) (1988) 1.35
Central nervous system infections in patients with cancer. Medicine (Baltimore) (1973) 1.34
Management of central nervous system metastases. Semin Oncol (1977) 1.32
Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology (1994) 1.32
The diagnosis of stupor and coma. Contemp Neurol Ser (1972) 1.26
Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology (1991) 1.26
Headaches in patients with brain tumors: a study of 111 patients. Neurology (1993) 1.25
Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology (1988) 1.22
Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol (1973) 1.22
Hyponatremia in acute polyneuropathy. Four cases with the syndrome of inappropriate secretion of antidiuretic hormone. Arch Neurol (1967) 1.21
Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology (1992) 1.21
Brain metastasis from melanoma. J Neurooncol (1983) 1.21
Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. Cancer Res (1998) 1.20
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci U S A (1990) 1.19
Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol (1994) 1.19
Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology (1988) 1.19
Human brain tumor transplantation into nude mice. J Natl Cancer Inst (1979) 1.18
T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology (1998) 1.18
Sclerosing epithelioid fibrosarcomas involving the neuraxis: report of three cases. Neurosurgery (2000) 1.18
Spinal subdural hematomas complicating lumbar puncture. Arch Neurol (1974) 1.17
Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (1996) 1.16
Treatment of experimental spinal cord compression caused by extradural neoplasms. J Neurosurg (1977) 1.15
Extraneural metastases of infratentorial glioblastoma multiforme to the peritoneal cavity. Cancer (1992) 1.14